Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder (ON-ICE)
Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder - a Randomized Double-blind Placebo-controlled Parallel-group Trial
Sponsor: Central Institute of Mental Health, Mannheim
A PHASE2/PHASE3 clinical study on Alcohol Addiction and Alcohol Use Disorder, this trial is completed. The trial is conducted by Central Institute of Mental Health, Mannheim and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed
-
Apr 2023 — Apr 2024 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2022 — Apr 2023 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Dec 2021 — Mar 2022 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Nov 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Central Institute of Mental Health, Mannheim
- German Federal Ministry of Education and Research
- Heidelberg University - Coordination Centre for Clinical Trials (KKS) of Heidelberg University
- Heidelberg University - Institute of Medical Biometry (IMBI)
For direct contact, visit the study record on ClinicalTrials.gov .